Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy.

Takei, Akinori; Sakamoto, Shinichi; Wakai, Ken; Tamura, Takaaki; Imamura, Yusuke; Xu, Minhui; Maimaiti, Maihulan; Kawamura, Koji; Imamoto, Takashi; Komiya, Akira; Akakura, Koichiro; Ichikawa, Tomohiko

Takei, Akinori; Sakamoto, Shinichi; Wakai, Ken; Tamura, Takaaki; Imamura, Yusuke; Xu, Minhui; Maimaiti, Maihulan; Kawamura, Koji; Imamoto, Takashi; Komiya, Akira; Akakura, Koichiro; Ichikawa, Tomohiko.

Afiliação

Takei A; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Sakamoto S; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Wakai K; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Tamura T; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Imamura Y; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Xu M; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Maimaiti M; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Kawamura K; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Imamoto T; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Komiya A; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Akakura K; Department of Urology, Japan Community Healthcare Organization Tokyo Shinjuku Medical Center, Tokyo, Japan.
Ichikawa T; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.

Int J Urol ; 25(4): 352-358, 2018 04.

Article em En | MEDLINE | ID: mdl-29323427

Assuntos

Antagonistas de Androgênios/administração & dosagem; Neoplasias da Próstata/terapia; Testosterona/sangue; Idoso; Idoso de 80 Anos ou mais; Quimioterapia Adjuvante/métodos; Progressão da Doença; Intervalo Livre de Doença; Humanos; Estimativa de Kaplan-Meier; Masculino; Terapia Neoadjuvante/métodos; Modelos de Riscos Proporcionais; Próstata/efeitos dos fármacos; Próstata/efeitos da radiação; Antígeno Prostático Específico/sangue; Neoplasias da Próstata/sangue; Neoplasias da Próstata/mortalidade; Estudos Retrospectivos; Fatores de Risco; Fatores de Tempo

Palavras-chave

androgen deprivation therapy; nadir testosterone; prostate cancer; radiation therapy; testosterone recovery

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Testosterona / Antagonistas de Androgênios Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male Idioma: En Revista: Int J Urol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google